Want to join the conversation?
Marlborough, Massachusetts-based $BSX said it delivered 5% organic and 8% operational revenue growth in 2015, which includes the acquired sales from Bayer peripheral & American Medical Systems. $BSX expects to deliver 25% plus adjusted operating margin in 2017, with plans to deliver an additional 200-300 BPs of improvement by year-end 2020.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?